SeaStar Medical

NASDAQ: ICU · Real-Time Price · USD
0.81
-0.07 (-7.95%)
At close: Aug 15, 2025, 3:59 PM
0.81
0.06%
After-hours: Aug 15, 2025, 07:57 PM EDT

SeaStar Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
338K 293K 67K 68K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
27K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
311K 293K 67K 68K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-1.76M -3.82M -4.77M -4.46M -4.67M -3.95M -2.94M -2.94M -3.75M -4.58M -7.72M -1.77M -1.31M -812K -375K -1.16M -1.19M -1.06M
Interest Income
45K 48K 19K 58K 25K n/a n/a 224.00 225.00 433.00 147.00 n/a n/a n/a 147K 54K n/a n/a
Pretax Income
-2M -3.77M -4.42M -4.48M -3.23M -12.7M -9.88M -7.43M -3.66M -5.26M -19.21M -1.89M -902K -1M -1.22M 235.98K -1.11M -1.06M
Net Income
-2M -3.77M -4.42M -4.48M -3.24M -12.7M -9.88M -7.43M -3.67M -5.26M -25.96M -1.89M -902K -1M 115.58K 235.98K -1.11M -1.06M
Selling & General & Admin
1.03M 1.68M 2.1M 2.19M 2.33M 2.25M 1.96M 1.83M 1.74M 2.8M 4.38M 1.04M 716K 457K 375.37K 411.4K 652K 316K
Research & Development
1.04M 2.43M 2.74M 2.34M 2.33M 1.7M 1.18M 1.11M 2.01M 1.78M 1.14M 727K 596K 355K 499K 985K 536K 746K
Other Expenses
n/a n/a n/a n/a n/a n/a -193.8K n/a n/a n/a 2.19M n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
2.07M 4.12M 4.83M 4.52M 4.67M 3.95M 2.94M 2.94M 3.75M 4.58M 7.72M 1.77M 1.31M 812K 375.37K 411.4K 1.19M 1.06M
Interest Expense
-9K 11K -253K 272K 82K 143K 199K 224K 225K 433K 147K 123K 191K 169K n/a n/a 9K 2K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a 32K n/a n/a n/a n/a n/a n/a n/a 8K 8K n/a n/a
Cost & Expenses
2.09M 4.12M 4.83M 4.52M 4.67M 3.95M 2.94M 2.94M 3.75M 4.58M 7.72M 1.77M 1.31M 812K 375.37K 411.4K 1.19M 1.06M
Income Tax Expense
n/a 3K n/a n/a 3K n/a -5K n/a 5K n/a 147K 1K n/a n/a -1.04M 2K 9K 1K
Shares Outstanding (Basic)
11.33B 8.62M 4.92M 4.09M 3.15M 2.68M 1.54M 801K 597K 521K 445K 289K 289K 289K 521.64K 521.64K 507.99K 521.64K
Shares Outstanding (Diluted)
11.33B 8.62M 4.92M 4.09M 3.15M 2.68M 1.54M 801.94K 597.32K 521.03K 445.15K 507.99K 289.55K 289.55K 521.64K 521.64K 507.99K 521.64K
EPS (Basic)
-0.18 -0.44 -0.9 -1.1 -1.03 -4.73 -6.4 -9.02 -4.1 -13.5 -43.18 -2.14 -3.12 -1.98 0.40 1.15 -9.17 -8.83
EPS (Diluted)
-0.18 -0.44 -0.9 -1.1 -1.03 -4.73 -6.4 -9.02 -4.1 -13.5 -43.17 -3.72 -3.12 -1.98 0.40 1.15 -9.17 -8.83
EBITDA
-1.76M -3.76M -4.67M -4.21M -3.15M -12.55M -9.68M -7.01M -2.22M -4.58M -19.07M -270K 182.56K -835K n/a n/a -1.1M -1.06M
EBIT
n/a -3.76M -4.42M -4.21M -3.15M -12.55M -9.68M -7.01M -3.44M -6.66M -19.07M -1.77M -1.31M -812K -1.04M -1.16M -1.98M -1.06M
Depreciation & Amortization
n/a 3.82M -253K 250K 1.52M 3.95M n/a n/a 3.75M 4.58M -3.89M 1.77M 1.31M 812K 1.04M 1.16M n/a n/a